iVeena Delivery Systems develops non-surgical, non-invasive pharmacologic innovations to address unmet needs in treating corneal disease and myopic conditions. The company's lead programs include proprietary eye drops such as IVMED-80 for keratoconus and IVMED-85 for myopia.

iVeena

iVeena Delivery Systems

iVeena | 364 followers on LinkedIn. Lead programs comprise of novel proprietary eye drops; IVMED-80 (granted ODD) for keratoconus, and IVMED-85 for myopia

 | iVeena is a clinical stage ophthalmology company developing a non-surgical, non-invasive, pharmacologic innovation. This novel disease modifying intervention addresses a significant unmet need in the advancement of corneal diseases and myopic conditions.

The company’s lead programs comprise of novel proprietary products; IVMED-80 for keratoconus and IVMED-85 for myopia.

IVEE

COM:IVEENAMED

iVeena Delivery Systems

name

homepage url

country

linkedin url

crunchbase url

sector

industry

stage

raised capital

Description

peer of

competitor of

Metrics